Home › Funds › ZEVENBERGEN CAPITAL INVESTMENTS LLC › CAI

ZEVENBERGEN CAPITAL INVESTMENTS LLC position in CAI

CARIS LIFE SCIENCES INC · Health Care

ZEVENBERGEN CAPITAL INVESTMENTS LLC reported holding 719,597 shares of CAI (CARIS LIFE SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 0.56% of its reported portfolio and ranking #43 among its reported holdings. ZEVENBERGEN CAPITAL INVESTMENTS LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)719.60K sh
Reported value held$22.04M
Portfolio Weight0.56%
First reportedQ4 2025
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How ZEVENBERGEN CAPITAL INVESTMENTS LLC's CAI position evolved

ZEVENBERGEN CAPITAL INVESTMENTS LLC first disclosed a stake in CAI in Q4 2025 at 543,185 shares (US$14.7M). The position peaked in Q3 2026 at 719,597 shares, worth US$22.0M. Across 4 filings, ZEVENBERGEN CAPITAL INVESTMENTS LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 719,597 shares valued at US$22.0M — a reduction of -82,486 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2026 (shares rose 72% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 543.18K $14.66M New
Q1 2026 610.23K $10.91M Add
Q2 2026 802.08K $14.29M Add
Q3 2026 719.60K $22.04M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAI and 13F data

CAI (CARIS LIFE SCIENCES INC) is a Health Care company. 53 other funds we track also report a position in CAI — the largest reported positions include J. H. Whitney Equity Partners VI, LLC (US$200.6M), Coatue Management (US$175.0M), COATUE MANAGEMENT LLC (US$175.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAI

All CAI fund holders →

FAQ

How long has ZEVENBERGEN CAPITAL INVESTMENTS LLC held CAI?

ZEVENBERGEN CAPITAL INVESTMENTS LLC has disclosed CAI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is ZEVENBERGEN CAPITAL INVESTMENTS LLC's current position in CAI?

As of Q3 2026, ZEVENBERGEN CAPITAL INVESTMENTS LLC holds 719.60K shares of CAI (CARIS LIFE SCIENCES INC), valued at $22.04M, representing 0.56% of its reported portfolio and ranking #43.

Has ZEVENBERGEN CAPITAL INVESTMENTS LLC been buying or selling CAI?

In the latest 13F filing (Q3 2026), ZEVENBERGEN CAPITAL INVESTMENTS LLC reduced its position in CAI. The position peaked in Q3 2026 at 719.60K shares.

Which other funds hold CAI?

Other major institutional holders of CAI include J. H. Whitney Equity Partners VI, LLC, Coatue Management, COATUE MANAGEMENT LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.